OBJECTIVES: Determine rates and demographic, clinical, and functional correlates of antidepressants (ADs) in home healthcare patients. METHODS: Year 2007 cross-sectional National Home Health and Hospice Care Survey (N = 3,226) of patients 65 years or older (mean 80.11, confidence interval [CI] = 79.65-80.57). RESULTS: Overall 33.50% used ADs. Among the 6.76% with depression, 70.84% used ADs compared with 29.15% who used ADs without a documented depression diagnosis. In a regression, controlling for depression, blacks used less ADs than whites (odds ratio [OR] = 0.41, CI = 0.24-0.70). Younger age (OR = 0.96, CI = 0.94-0.98), activities of daily living impairments (OR = 1.15, CI = 1.05-1.26), benzodiazepines (OR = 2.63, CI = 1.88-3.69), antipsychotics (OR = 2.08, CI = 1.29-3.36), and nonpsychotropics (OR = 1.07, CI = 1.04-1.10) were related to AD use. CONCLUSION: Among home healthcare patients, more than one-third took ADs including patients without depression. Blacks used fewer ADs than whites. Increased use was associated with younger age, disability, and nonpsychotropics.
OBJECTIVES: Determine rates and demographic, clinical, and functional correlates of antidepressants (ADs) in home healthcare patients. METHODS: Year 2007 cross-sectional National Home Health and Hospice Care Survey (N = 3,226) of patients 65 years or older (mean 80.11, confidence interval [CI] = 79.65-80.57). RESULTS: Overall 33.50% used ADs. Among the 6.76% with depression, 70.84% used ADs compared with 29.15% who used ADs without a documented depression diagnosis. In a regression, controlling for depression, blacks used less ADs than whites (odds ratio [OR] = 0.41, CI = 0.24-0.70). Younger age (OR = 0.96, CI = 0.94-0.98), activities of daily living impairments (OR = 1.15, CI = 1.05-1.26), benzodiazepines (OR = 2.63, CI = 1.88-3.69), antipsychotics (OR = 2.08, CI = 1.29-3.36), and nonpsychotropics (OR = 1.07, CI = 1.04-1.10) were related to AD use. CONCLUSION: Among home healthcare patients, more than one-third took ADs including patients without depression. Blacks used fewer ADs than whites. Increased use was associated with younger age, disability, and nonpsychotropics.
Authors: Ellen L Brown; Patrick J Raue; Amy E Mlodzianowski; Barnett S Meyers; Rebecca L Greenberg; Martha L Bruce Journal: Int J Psychiatry Med Date: 2006 Impact factor: 1.210
Authors: Harry S Strothers; George Rust; Patrick Minor; Edith Fresh; Benjamin Druss; David Satcher Journal: J Am Geriatr Soc Date: 2005-03 Impact factor: 5.562
Authors: Martha L Bruce; Gail J McAvay; Patrick J Raue; Ellen L Brown; Barnett S Meyers; Denis J Keohane; David R Jagoda; Carol Weber Journal: Am J Psychiatry Date: 2002-08 Impact factor: 18.112
Authors: Hector M González; Thomas Croghan; Brady West; David Williams; Randolph Nesse; Wassim Tarraf; Robert Taylor; Ladson Hinton; Harold Neighbors; James Jackson Journal: Psychiatr Serv Date: 2008-10 Impact factor: 4.157
Authors: Namkee G Choi; C Nathan Marti; Martha L Bruce; Mark T Hegel; Nancy L Wilson; Mark E Kunik Journal: Depress Anxiety Date: 2014-02-05 Impact factor: 6.505
Authors: Yolonda R Pickett; Kisha N Bazelais; Rebecca L Greenberg; Martha L Bruce Journal: Int J Geriatr Psychiatry Date: 2013-11-15 Impact factor: 3.485